Lanma Medical

蓝马医疗

Lanma Medical

Biotech/Healthcare

Founded in December 2020, Lanma Medical develops cellular immunotherapies centered on tumor-infiltrating lymphocyte (TIL) therapy, offering patients new treatment options. TILs are lymphocytes that infiltrate tumor tissue and recognize, resist, and attack tumors.

Latest round: Series A (2024)

Source: ChinaBulls — chinabulls.com

Last updated 2024-12-01